<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0265">
 <label>53</label>
 <mixed-citation publication-type="other" id="or0065">Roivant announces development of anti-GM-CSF monoclonal antibody to prevent and treat acute respiratory distress syndrome (ARDS) in patients with COVID-19|Roivant Sciences, (n.d). https://roivant.com/roivant-announces-development-of-anti-gm-csf-monoclonal-antibody-to-prevent-and-treat-acute-respiratory-distress-syndrome-ards-in-patients-with-covid-19.html (accessed June 15, 2020).</mixed-citation>
</ref>
